[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Springer Nature Link
Log in

The Role of Rehabilitation in Optimizing Bone Health in Cancer Survivors

  • Review
  • Published:
Current Physical Medicine and Rehabilitation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This manuscript aims to highlight the vital role of physiatrists in optimizing bone health for cancer survivors within the cancer care continuum.

Recent Findings

Positioned uniquely to enhance rehabilitation, physiatrists address the specific challenges that arise from cancer treatments and their impact on bone health, ultimately improving patients' functionality and quality of life. By collaborating with multidisciplinary teams, including oncologists, nutritionists, and physical therapists, they can create tailored rehabilitation programs that consider each patient's treatment history and current condition. Continuous patient education is crucial, empowering individuals to actively engage in their care and make informed decisions regarding bone health management.

Summary

Through this holistic approach, physiatrists significantly mitigate risks associated with bone fragility, pathologic fractures, and pain, helping cancer survivors maintain their independence and overall well-being throughout their recovery journey. This underscores the importance of integrating effective bone health management into the broader framework of cancer care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

  1. American Cancer Society. Cancer treatment & survivorship facts & figures 2022–2024. Atlanta: American Cancer Society; 2022.

    Google Scholar 

  2. Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, et al. Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol. 2020;31(12):1650–63.

    Article  CAS  PubMed  Google Scholar 

  3. Johnson E. Bone health in patients with prostate cancer: an evidence-based algorithm. Fed Pract [Internet]. 2021 ;38(Suppl 3). Available from: https://www.mdedge.com/fedprac/article/244416/colon-and-rectal/bone-health-patients-prostate-cancer-evidence-based. Accessed 8 Sept 2024.

  4. Wissing MD. Chemotherapy- and irradiation-induced bone loss in adults with solid tumors. Curr Osteoporos Rep. 2015;13(3):140–5.

    Article  PubMed  Google Scholar 

  5. Lustberg MB, Reinbolt RE, Shapiro CL. Bone health in adult cancer survivorship. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(30):3665–74.

    Article  CAS  Google Scholar 

  6. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337–42.

    Article  CAS  PubMed  Google Scholar 

  7. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115–37.

    CAS  PubMed  Google Scholar 

  8. Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008;29(2):155–92.

    Article  CAS  PubMed  Google Scholar 

  9. Taran SJ, Taran R, Malipatil NB. Pediatric osteosarcoma: an updated review. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 2017;38(1):33–43.

    Article  Google Scholar 

  10. Ibrahim T, Mercatali L, Amadori D. Bone and cancer: the osteoncology. Clin Cases Miner Bone Metab Off J Ital Soc Osteoporos Miner Metab Skelet Dis. 2013;10(2):121–3.

    Google Scholar 

  11. Pullan JE, Lotfollahzadeh S. Primary bone cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560830/ . Accessed 8 Sept 2024.

  12. Papagelopoulos PJ, Mavrogenis AF, Savvidou OD, Benetos IS, Galanis EC, Soucacos PN. Pathological fractures in primary bone sarcomas. Injury. 2008;39(4):395–403.

    Article  PubMed  Google Scholar 

  13. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112(1):138–49.

    Article  CAS  PubMed  Google Scholar 

  14. Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411–25.

    Article  CAS  PubMed  Google Scholar 

  15. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res Off J Am Assoc Cancer Res. 2006;12(20 Pt 2):6243s-s6249.

    Article  Google Scholar 

  16. Komori T. Glucocorticoid signaling and bone biology. Horm Metab Res Horm Stoffwechselforschung Horm Metab. 2016;48(11):755–63.

    Article  CAS  Google Scholar 

  17. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci. 2002;966:73–81.

    Article  CAS  PubMed  Google Scholar 

  18. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7–16.

    Article  CAS  PubMed  Google Scholar 

  19. Weinstein RS, Hogan EA, Borrelli MJ, Liachenko S, O’Brien CA, Manolagas SC. The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice. Endocrinology. 2017;158(11):3817–31.

    Article  CAS  PubMed  Google Scholar 

  20. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050–5.

    Article  CAS  PubMed  Google Scholar 

  21. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 1996;14(5):1718–29.

    Article  CAS  Google Scholar 

  22. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(14):3306–11.

    Article  CAS  Google Scholar 

  23. Shandala T, Shen Ng Y, Hopwood B, Yip YC, Foster BK, Xian CJ. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol. 2012;227(7):2889–97.

    Article  CAS  PubMed  Google Scholar 

  24. Georgiou KR, King TJ, Scherer MA, Zhou H, Foster BK, Xian CJ. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. Bone. 2012;50(6):1223–33.

    Article  CAS  PubMed  Google Scholar 

  25. Shandala T, Shen Ng Y, Hopwood B, Yip YC, Foster BK, Xian CJ. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol. 2012;227(7):2889–97.

    Article  CAS  PubMed  Google Scholar 

  26. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.

    Article  CAS  Google Scholar 

  27. Stuart NS, Woodroffe CM, Grundy R, Cullen MH. Long-term toxicity of chemotherapy for testicular cancer–the cost of cure. Br J Cancer. 1990;61(3):479–84.

    Article  CAS  PubMed  Google Scholar 

  28. Bassett JHD, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016;37(2):135–87.

    Article  CAS  PubMed  Google Scholar 

  29. Delitala AP, Scuteri A, Doria C. Thyroid hormone diseases and osteoporosis. J Clin Med. 2020;9(4):1034.

    Article  CAS  PubMed  Google Scholar 

  30. Nishimoto H, Inui A, Mifune Y, Yamaura K, Bando Y, Okamura Y, et al. Treatment of osteoporosis in men on androgen deprivation therapy in Japan. Med Kaunas Lith. 2024;60(4):551.

    Google Scholar 

  31. Mohamad NV, Soelaiman IN, Chin KY. A concise review of testosterone and bone health. Clin Interv Aging. 2016;11:1317–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Beebe-Dimmer JL, Cetin K, Shahinian V, Morgenstern H, Yee C, Schwartz KL, et al. Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States. Pharmacoepidemiol Drug Saf. 2012;21(1):70–8.

    Article  PubMed  Google Scholar 

  33. O’Farrell S, Garmo H, Holmberg L, Adolfsson J, Stattin P, Van Hemelrijck M. Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer. J Clin Oncol. 2015;33(11):1243–51.

    Article  PubMed  Google Scholar 

  34. Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, et al. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(7):1051–7.

    Article  CAS  Google Scholar 

  35. Malagrinò M, Zavatta G. Review of bone health in women with estrogen receptor-positive breast cancer receiving endocrine therapy. Womens Health Lond Engl. 2023;19:17455057221149492.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Geisler J, Haynes B, Anker G, Dowsett M, Lønning PE. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(3):751–7.

    Article  CAS  Google Scholar 

  37. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol Off J Am Soc Clin Oncol. 1996;14(1):78–84.

    Article  CAS  Google Scholar 

  38. Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299–309.

    Article  CAS  PubMed  Google Scholar 

  39. Williams HJ, Davies AM. The effect of X-rays on bone: a pictorial review. Eur Radiol. 2006;16(3):619–33.

    Article  CAS  PubMed  Google Scholar 

  40. Matsumura S, Jikko A, Hiranuma H, Deguchi A, Fuchihata H. Effect of X-ray irradiation on proliferation and differentiation of osteoblast. Calcif Tissue Int. 1996;59(4):307–8.

    Article  CAS  PubMed  Google Scholar 

  41. Szymczyk KH, Shapiro IM, Adams CS. Ionizing radiation sensitizes bone cells to apoptosis. Bone. 2004;34(1):148–56.

    Article  CAS  PubMed  Google Scholar 

  42. Longo J, Lutz S, Johnstone C. Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases. Cancer Manag Res. 2013;5:235–42.

    PubMed  Google Scholar 

  43. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.

    Article  CAS  PubMed  Google Scholar 

  44. Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, et al. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology. 2004;63(5):940–5.

    Article  PubMed  Google Scholar 

  45. Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2016;27(4):1281–386.

    Article  CAS  Google Scholar 

  46. Baxter-Jones ADG, Kontulainen SA, Faulkner RA, Bailey DA. A longitudinal study of the relationship of physical activity to bone mineral accrual from adolescence to young adulthood. Bone. 2008;43(6):1101–7.

    Article  PubMed  Google Scholar 

  47. Rolvien T, Amling M. Disuse osteoporosis: clinical and mechanistic insights. Calcif Tissue Int. 2022;110(5):592–604.

    Article  CAS  PubMed  Google Scholar 

  48. Mantyh PW, Hunt SP. Mechanisms that generate and maintain bone cancer pain. Novartis Found Symp. 2004;260:221–38 (discussion238-240,277–9).

    Article  PubMed  Google Scholar 

  49. Sindhi V, Erdek M. Interventional treatments for metastatic bone cancer pain. Pain Manag. 2019;9(3):307–15.

    Article  PubMed  Google Scholar 

  50. Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(16):1647–54.

    Article  CAS  Google Scholar 

  51. Laird BJA, Walley J, Murray GD, Clausen E, Colvin LA, Fallon MT. Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2011;19(9):1393–401.

    Google Scholar 

  52. Rajeswaran T, Wong HCY, Zhang E, Kennedy SKF, Gojsevic M, Soliman H, et al. Quality of life issues in patients with bone metastases: a systematic review. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2023;32(1):18.

    Google Scholar 

  53. Vakiti A, Anastasopoulou C, Mewawalla P. Malignancy-related hypercalcemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482423/. Accessed 8 Sept 2024.

  54. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–93.

    Article  CAS  PubMed  Google Scholar 

  55. Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res Off J Am Soc Bone Miner Res. 1992;7(2):221–7.

    Article  CAS  Google Scholar 

  56. Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Phys. 2012;84(2):312–7.

    Article  PubMed  Google Scholar 

  57. Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. 2010;35(22):E1221-1229.

    Article  PubMed  Google Scholar 

  58. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2011;22(9):2395–411.

    Article  CAS  Google Scholar 

  60. Jawad MU, Scully SP. In brief: classifications in brief: Mirels’ classification: metastatic disease in long bones and impending pathologic fracture. Clin Orthop. 2010;468(10):2825–7.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop. 1989;249:256–64.

    Article  Google Scholar 

  62. Wang Y, Yu P, Liu F, Wang Y, Zhu J. Clinical value of ultrasound for the evaluation of local recurrence of primary bone tumors. Front Oncol. 2022;15(12):902317.

    Article  Google Scholar 

  63. Löffler MT, Sollmann N, Mei K, Valentinitsch A, Noël PB, Kirschke JS, et al. X-ray-based quantitative osteoporosis imaging at the spine. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2020;31(2):233–50.

    Article  Google Scholar 

  64. Bansal A, Dhamija E, Chandrashekhara SH, Sahoo RK. Role of CT in the detection and management of cancer related complications: a study of 599 patients. Ecancermedicalscience. 2023;17:1529.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J. 2007;83(982):509–17.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Krugh M, Langaker MD. Dual-energy X-ray absorptiometry. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK519042/ . Accessed 8 Sept 2024.

  67. Peppone LJ, Mustian KM, Janelsins MC, Palesh OG, Rosier RN, Piazza KM, et al. Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer. 2010;10(3):224–9.

    Article  PubMed  Google Scholar 

  68. Mosti MP, Kaehler N, Stunes AK, Hoff J, Syversen U. Maximal strength training in postmenopausal women with osteoporosis or osteopenia. J Strength Cond Res. 2013;27(10):2879–86.

    Article  PubMed  Google Scholar 

  69. Singh B, Toohey K. The effect of exercise for improving bone health in cancer survivors - a systematic review and meta-analysis. J Sci Med Sport. 2022;25(1):31–40.

    Article  PubMed  Google Scholar 

  70. Bemben DA, Bemben MG. Dose-response effect of 40 weeks of resistance training on bone mineral density in older adults. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2011;22(1):179–86.

    Article  CAS  Google Scholar 

  71. Kohrt WM, Bloomfield SA, Little KD, Nelson ME, Yingling VR, American College of Sports Medicine. American college of sports college of sports medicine position stand: physical activity and bone health. Med Sci Sports Exerc. 2004;36(11):1985–96.

    Article  PubMed  Google Scholar 

  72. Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Mohile S. Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: a review. Oncol Hematol Rev. 2012;8(2):81–8.

    PubMed  Google Scholar 

  73. Bunting RW, Shea B. Bone metastasis and rehabilitation. Cancer. 2001;92(S4):1020–8.

    Article  CAS  PubMed  Google Scholar 

  74. Al-Bashaireh AM, Haddad LG, Weaver M, Chengguo X, Kelly DL, Yoon S. The effect of tobacco smoking on bone mass: an overview of pathophysiologic mechanisms. J Osteoporos. 2018;2018:1206235.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Geisler J, Omsjø IH, Helle SI, Ekse D, Silsand T, Lønning PE. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinol. 1999;162(2):265–70.

    Article  CAS  PubMed  Google Scholar 

  76. Pompe E, Bartstra J, Verhaar HJ, de Koning HJ, van der Aalst CM, Oudkerk M, et al. Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers. Eur J Radiol. 2017;89:177–81.

    Article  CAS  PubMed  Google Scholar 

  77. Sampson HW. Alcohol’s harmful effects on bone. Alcohol Health Res World. 1998;22(3):190–4.

    CAS  PubMed  Google Scholar 

  78. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 2005;81(5):1232S-1239S.

    Article  CAS  PubMed  Google Scholar 

  79. Teucher B, Fairweather-Tait S. Dietary sodium as a risk factor for osteoporosis: where is the evidence? Proc Nutr Soc. 2003;62(4):859–66.

    CAS  PubMed  Google Scholar 

  80. Harrington M, Cashman KD. High salt intake appears to increase bone resorption in postmenopausal women but high potassium intake ameliorates this adverse effect. Nutr Rev. 2003;61(5 Pt 1):179–83.

    PubMed  Google Scholar 

  81. Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL. Cancer- and chemotherapy-induced musculoskeletal degradation. JBMR Plus. 2019;3(3):e10187.

    Article  PubMed  Google Scholar 

  82. Tang V, Harvey D, Park Dorsay J, Jiang S, Rathbone MP. Prognostic indicators in metastatic spinal cord compression: using functional independence measure and Tokuhashi scale to optimize rehabilitation planning. Spinal Cord. 2007;45(10):671–7.

    Article  CAS  PubMed  Google Scholar 

  83. Jing D, Zhao Q, Zhao Y, Lu X, Feng Y, Zhao B, et al. Management of pain in patients with bone metastases. Front Oncol. 2023;13:1156618.

    Article  CAS  PubMed  Google Scholar 

  84. Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020;34(4):444–53.

    Article  PubMed  Google Scholar 

  85. Alarcón MDL, Estévez FV, Cabezón-Gutiérrez L, Padrós MC, Martín-Arroyo JMT, Rebollo MA, et al. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study. J Geriatr Oncol. 2019;10(4):643–52.

    Article  PubMed  Google Scholar 

  86. Rizzo SE, Kenan S. Pathologic fractures. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK559077/. Accessed 8 Sept 2024.

  87. D’Oronzo S, Coleman R, Brown J, Silvestris F. Metastatic bone disease: Pathogenesis and therapeutic options. J Bone Oncol. 2019;15:100205.

    Article  Google Scholar 

  88. Alsoof D, Anderson G, McDonald CL, Basques B, Kuris E, Daniels AH. Diagnosis and Management of Vertebral Compression Fracture. Am J Med. 2022;135(7):815–21.

    Article  PubMed  Google Scholar 

  89. McDonald CL, Alsoof D, Daniels AH. Vertebral compression fractures. R I Med J 2013. 2022;105(8):40–5.

    PubMed  Google Scholar 

  90. Cheville AL, Basford JR. Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain. J Clin Oncol. 2014;32(16):1691–702.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Vander Kooi D, Abad G, Basford JR, Maus TP, Yaszemski MJ, Kaufman KR. Lumbar spine stabilization with a thoracolumbosacral orthosis: evaluation with video fluoroscopy. Spine. 2004;29(1):100–4.

    Article  PubMed  Google Scholar 

  92. Tescher AN, Rindflesch AB, Youdas JW, Jacobson TM, Downer LL, Miers AG, et al. Range-of-motion restriction and craniofacial tissue-interface pressure from four cervical collars. J Trauma. 2007;63(5):1120–6.

    PubMed  Google Scholar 

  93. McCall T, Cole C, Dailey A. Vertebroplasty and kyphoplasty: a comparative review of efficacy and adverse events. Curr Rev Musculoskelet Med. 2008;1(1):17–23.

    Article  PubMed  Google Scholar 

  94. Huang MH, Shilling T, Miller KA, Smith K, LaVictoire K. History of falls, gait, balance, and fall risks in older cancer survivors living in the community. Clin Interv Aging. 2015;10:1497–503.

    Article  PubMed  Google Scholar 

  95. Itokazu M, Higashimoto Y, Ueda M, Hanada K, Murakami S, Fukuda K. Effectiveness of Rehabilitation for Cancer Patients with Bone Metastasis. Prog Rehabil Med. 2022;7:20220027.

    Article  PubMed  Google Scholar 

  96. Coleman RE, McCloskey EV. Bisphosphonates in oncology. Bone. 2011;49(1):71–6.

    Article  CAS  PubMed  Google Scholar 

  97. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003;98(8):1735–44.

    Article  CAS  PubMed  Google Scholar 

  98. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2009;67(5 Suppl):61–70.

    Article  Google Scholar 

Download references

Funding

This research received no funding.

Author information

Authors and Affiliations

  1. Department of Rehabilitation Medicine – Program Director of Inpatient Cancer Rehabilitation, Emory University, 1441 Clifton Road, Atlanta, GA, 30322, USA

    Noble G. Jones

  2. Department of Cancer Rehabilitation – Post Doctoral Fellow, Kessler Foundation, 1199 Pleasant Valley Way, West Orange, NJ, 07052, USA

    Diana H. Presno Rubin

Authors
  1. Noble G. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diana H. Presno Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

N.J. wrote the initial draft of the main manuscript text. D.P.R. assisted in development of the outline, wrote the Introduction, Bracing and made significant writing contributions for each section in the main text. All authors reviewed the manuscript.

Corresponding author

Correspondence to Noble G. Jones.

Ethics declarations

Human and Animal Rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jones, N.G., Presno Rubin, D.H. The Role of Rehabilitation in Optimizing Bone Health in Cancer Survivors. Curr Phys Med Rehabil Rep 12, 442–454 (2024). https://doi.org/10.1007/s40141-024-00471-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40141-024-00471-5

Keywords

Search

Navigation